Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab

NCT04592952 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.

NCT NCT04592952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04592952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
Lead sponsor
Danish Headache Center
Phase
Phase 4
Overall status
Unknown status
Start date
October 8, 2020
Completion date
August 1, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine